Liver Cancer

Radiofrequency ablation liver treatment establishes reimbursement policies

Published in Health and Medicine Week, March 29th, 2004

Rita Medical Systems, Inc., (RITA) announced that several Blue Cross Blue Shield systems in the U.S. have established positive written reimbursement policies for the treatment of liver cancer with radiofrequency ablation (RFA).

Payers reviewing reimbursement policies often rely on third-party technology assessments and clinical data, including the 2003 Blue Cross Blue Shield Technology Evaluation Committee (BCBS TEC) review, ECRI Technology Assessment, and recently published clinical data.

Mr. Joseph DeVivo, president and chief executive officer of Rita Medical Systems stated, "We are pleased that many of the nation's private health insurance...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week

Source: Health and Medicine Week (2004-03-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry